Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesCJC-1295 for Women: Optimising Healthspan by 2026
CJC-1295, a GHRH analogue, offers potential for women's healthspan, but hormonal nuances and specific considerations are key for safe, effective use.
PeptidesTesamorelin Explained: Deep Dive into Fat Loss & Longevity by 2026
Tesamorelin, a synthetic GHRH analogue, offers a targeted approach to reducing visceral fat and optimising the growth hormone axis. This deep dive unpacks its science.
PeptidesPinealon: Unveiling the Cognitive Resilience Evidence
Explore Pinealon's cutting-edge research, with a focus on new 2025-2026 clinical evidence for cognitive resilience, mechanisms, and revised recommendations.
PeptidesARA-290 Stacking & Synergy for Healthspan in 2026:
Discover how ARA-290 (Cibinetide) can be effectively stacked with other compounds to amplify benefits for longevity and healthspan.
PeptidesEpithalon After 50: Reversing Ageing Biomarkers
A deep dive into Epithalon's efficacy for individuals over 50, examining its impact on telomeres, sleep, and overall healthspan.
PeptidesCJC-1295: 2026’s Latest Evidence on Growth
Dive into the newest 2026 evidence surrounding CJC-1295 with DAC, examining its role in growth hormone modulation, clinical efficacy, and safety profile.
PeptidesIpamorelin in the UK: Sourcing & Cost
A deep dive into Ipamorelin's legal standing, pricing trends, and safe sourcing practices within the UK market for those considering this selective GH secretagogue.
PeptidesEpithalon Stacking Strategies for Longevity:
Discover how Epithalon stacks with other compounds for advanced longevity strategies. Learn about synergistic mechanisms, optimal pairings, and real-world applications.
PeptidesCJC-1295: Latest Clinical Evidence & Safety
Dive into the latest 2026 clinical evidence for CJC-1295 with DAC, examining its mechanisms, revised benefits, and safety considerations for healthspan optimisation.
PeptidesCJC-1295 in 2026: Unpacking the Latest Evidence
Dive into the cutting-edge research on CJC-1295 (with DAC) from 2025-2026, examining new clinical trials, revised recommendations, and its place in longevity strategies.
PeptidesPinealon: Latest Cognitive Resilience Evidence
Dive into the newest clinical trials and meta-analyses concerning Pinealon's role in cognitive resilience, reflecting 2026's scientific landscape.
PeptidesOptimising SS-31 (Elamipretide) Dosing for
Understanding the nuanced dosing and protocol for SS-31 (Elamipretide) is paramount for maximising its mitochondrial-targeted benefits, from enhanced recovery to improved healthspan.
PeptidesPinealon's Metabolic Edge: Optimising
Investigate Pinealon's emerging role in metabolic health, focusing on glucose regulation and insulin sensitivity.
PeptidesSS-31 Stacks for Longevity in 2026: Optimal
SS-31, a potent mitochondrial peptide, shines brightest when combined thoughtfully. This guide explores optimal stacking strategies for enhanced longevity.
PeptidesIpamorelin Stacking Strategies for Healthspan
Ipamorelin, a selective GH secretagogue, offers significant anti-aging potential. This deep dive explores its synergy with other compounds for enhanced healthspan benefits.
PeptidesMOTS-c Stacks for Longevity in 2026:
Discover how MOTS-c, a mitochondrial-derived peptide, can be synergistically stacked with other compounds to boost longevity efforts.
PeptidesCJC-1295 Stacks: Synergistic Longevity for 2026
Discover how CJC-1295 can be strategically stacked with other compounds to amplify its benefits for longevity, focusing on cognitive function, recovery, and metabolic health.
PeptidesMOTS-c Peptide: 2026 Evidence and Revised
New 2025-2026 clinical data reshapes our understanding of the MOTS-c peptide. We analyse the latest evidence, updating efficacy, safety, and usage recommendations.
PeptidesEpithalon for Women: Hormone Balance &
Epithalon, a synthetic tetrapeptide, holds intriguing possibilities for women seeking to optimise health and longevity, particularly around hormonal shifts.
PeptidesBPC-157: Latest 2026 Evidence and Revised
New 2026 clinical data reshapes our understanding of BPC-157. This deep dive critically assesses its tissue repair and gut integrity mechanisms, offering revised guidance.
PeptidesBPC-157 Stacking Strategies for 2026: Synergies
Exploring BPC-157 stacking for maximal therapeutic benefit. Learn which compounds pair best, why, and how to safely dose for recovery, gut integrity, and more.
PeptidesBPC-157 Dosing Strategies for 2026: An Expert
Understanding BPC-157 dosing is crucial. This guide covers clinically relevant dose ranges, titration, and cycling for various health goals, ensuring informed use by 2026.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.